# FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

> **NCT07181135** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **University Medical Center Groningen** · enrollment: 180 (estimated)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Finerenone (BAY 94-8862)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07181135
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-03-13
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07181135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07181135, "FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07181135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*